A Multicenter, Open-label, Long-term Extension Study for Oral Levosimendan (TNX-103)

Clinical Trial Grant

Duke Scholars

Principal Investigator Marat Fudim Medicine, Cardiology

Awarded By

Tenax Therapeutics, Inc.

Start Date

August 14, 2026

End Date

June 7, 2036

Awarded By

Tenax Therapeutics, Inc.

Start Date

August 14, 2026

End Date

June 7, 2036